Julia Fan Li
Seven Bridges Genomics
Julia is Senior Vice President at Seven Bridges Genomics based in London and is passionate about precision medicine. She works on accelerating biomedical discovery through whole genome analysis for cancer and rare diseases.
Julia is focused on oncology R&D and biomedical innovation using innovative finance. Previously, she helped originate, launch, and manage the pioneering $108M Global Health Investment Fund that focuses on innovation for diseases which disproportionately affect developing countries. The Fund was structured by Lion's Head Global Partners, JP Morgan, and Chase and the Bill & Melinda Gates Foundation and launched during the UN General Assembly in 2013. The LP base included pension funds, national governments, pharmaceutical corporate venture arms and individuals.
During her career, Julia has served the World Health Assembly on special task forces on R&D financing and coordination. As a policy adviser, Julia has advised the UK government on international health policy and government of the Northwest Territories (Canada) on sub-national sovereign wealth funds structured to sustain benefits for future generations. She started her career in the national biotechnology practice of KPMG Canada and healthcare investment banking in China with the Balloch Group.
Education, Personal, and Fellowship
Julia completed her MPhil in bioscience enterprise and PhD engineering at St. John's College, University of Cambridge as a Gates Scholar. She holds a BCOM, with Honours, in finance and immunology from the University of British Columbia and is a Canadian Chartered Accountant.
Julia is a David Rockefeller Fellow at the Trilateral Commission, Trustee of the Gates Cambridge Scholarships, and was a Press Operations volunteer at three successive Olympic Games in Beijing (2008), Vancouver (2010), and London (2012). She also co-founded the African Innovation Prize business plan competition to spur entrepreneurship in Rwandan universities.
A member of Class 20, Julia completed her fellowship under the mentorship of Christopher Egerton-Warburton, Partner at Lion's Head Global Partners.